85-4457-45 [取扱停止]Tumor Necrosis Factor Receptor Superfamily Member 17, active (TNFRSF17), Recombinant, Human 100ug 348260
特徴
- Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK.
- Biological Activity:Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit APRIL-mediated proliferation of anti-IgM stimulated murine B cells is no less than 40ng/ml, corresponding to a specific activity of > 2.5x10e4 IU/mg in the presence of 100ng/ml human APRIL.
- Sequence:AGQCSQNEYF DSLLHACIPC QLRCSSNTPP LTCQRYCNAS VTNSVKGTNA
- Molecular Weight:5.4kD
- PubMed ID:1396583; 8165126; 11528522; 17825416; 10493829; 15616553; 10903733; 10801128; 10973284; 10908663; 12721620; 15542592
- Gene Name:TNFRSF17,BCM,BCMA
- Swiss Prot:Q02223
- Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:100ug
- Source Antigen:Recombinant, Human, E. coli
- Grade:Highly Purified
- Purity:≥98% as determined by SDS-PAGE and HPLC.
- Form:Lyophilized from 0.2 um filtered 30% acetonitrile, 0.1% TFA
- Molecular Weight Non Ab:5.4
- Swiss Prot Number:Q02223
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





